Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8681202rdf:typepubmed:Citationlld:pubmed
pubmed-article:8681202lifeskim:mentionsumls-concept:C0178540lld:lifeskim
pubmed-article:8681202lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:8681202lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:8681202pubmed:issue131lld:pubmed
pubmed-article:8681202pubmed:dateCreated1996-8-21lld:pubmed
pubmed-article:8681202pubmed:abstractTextIn recent years much has been learned about the cellular and molecular events underlying cerebral hypoxia-ischemia (HI). We review, from a molecular standpoint, the main pathogenetic theories in hypoxic-ischemic cerebral injury, including excitotoxicity, free radical damage, and the role of growth factors, proto-oncogenes and heat shock proteins. The various forms of cell death in the developing and adult brain (necrosis, apoptosis and delayed neuronal death) are reviewed, with an emphasis on gene regulation of naturally-occurring and HI-associated cell death. We report the expression of the immediate early gene c-fos and c-jun mRNAs and of HSP72 mRNA and protein in several models of cerebral HI. Gel agarose electrophoresis of extracted DNA and in situ end-labeling of fragmented DNA revealed that cell death in these models was associated with endonuclease(s) activation. We also pre-treated some animals with dexamethasone, a neuroprotective drug in a model of perinatal HI. High-dose dexamethasone prevented c-fos induction in cerebral regions sensitive to HI. This effect may be due to a functional antagonism, at the transcriptional level, between Fos and the glucocorticoid receptor.lld:pubmed
pubmed-article:8681202pubmed:languagespalld:pubmed
pubmed-article:8681202pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:citationSubsetIMlld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8681202pubmed:statusMEDLINElld:pubmed
pubmed-article:8681202pubmed:monthJullld:pubmed
pubmed-article:8681202pubmed:issn0210-0010lld:pubmed
pubmed-article:8681202pubmed:authorpubmed-author:FerresHHlld:pubmed
pubmed-article:8681202pubmed:authorpubmed-author:ReventósJJlld:pubmed
pubmed-article:8681202pubmed:authorpubmed-author:MunellFFlld:pubmed
pubmed-article:8681202pubmed:authorpubmed-author:MacayaAAlld:pubmed
pubmed-article:8681202pubmed:issnTypePrintlld:pubmed
pubmed-article:8681202pubmed:volume24lld:pubmed
pubmed-article:8681202pubmed:ownerNLMlld:pubmed
pubmed-article:8681202pubmed:authorsCompleteYlld:pubmed
pubmed-article:8681202pubmed:pagination855-64lld:pubmed
pubmed-article:8681202pubmed:dateRevised2009-5-28lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:meshHeadingpubmed-meshheading:8681202-...lld:pubmed
pubmed-article:8681202pubmed:year1996lld:pubmed
pubmed-article:8681202pubmed:articleTitle[Molecular factors of cerebral hypoxia-ischemia].lld:pubmed
pubmed-article:8681202pubmed:affiliationSecció de Neurología Infantil, Hospital Vall d'Hebron, Barcelona.lld:pubmed
pubmed-article:8681202pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8681202pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:8681202pubmed:publicationTypeReviewlld:pubmed
pubmed-article:8681202pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed